Bernd R. Seizinger, Director at Aprea Therapeutics, Inc. (APRE), bought 10,000 shares at $2.68 ($27K) on 2024-10-11, disclosed to the SEC on 2024-10-15.
Open-market purchase of $27k APRE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-03-14 | $100K | — | Filing → |
| APTO | BUY | 2023-09-25 | $53K | — | Filing → |
| APRE | BUY | 2023-06-08 | $37K | — | Filing → |